Madrigal Pharmaceuticals: Pay

Madrigal Pharmaceuticals paid its 6 named executives $52.0M in total in FY2025 (Dec). CEO Bill Sibold was paid $19.2M of that.

Pay$100 in the stock at the end of FY22 → $201
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Bill SiboldPresident and Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
3 years
David Soergel, M.D.Executive Vice President and Chief Medical Officer
FY2025 (Dec)
1 year
Rebecca Taub, M.D.Senior Scientific and Medical Advisor and Former President, Research & Development and Chief Medical Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Mardi C. DierExecutive Vice President and Chief Financial Officer
FY2025 (Dec)
FY2024 (Dec)
2 years
Carole HuntsmanExecutive Vice President and Chief Commercial Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
3 years
Shannon KelleyExecutive Vice President and Chief Legal Counsel
FY2025 (Dec)
FY2024 (Dec)
2 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 10 peers with pay on file was $13.9M. The CEO of Madrigal Pharmaceuticals was paid $19.2M, 38% above the median.

  1. 1Exelixis
  2. 2Halozyme Therapeutics
  3. 3Madrigal Pharmaceuticals
  4. 4BridgeBio Pharma
  5. 5Alnylam Pharmaceuticals
  6. 6INSMED
  7. 7Ionis Pharmaceuticals
  8. 8Ultragenyx Pharmaceutical
  9. 9Krystal Biotech
  10. 10CRISPR Therapeutics AG
  11. 11Neurocrine Biosciences
  12. 12Apellis PharmaceuticalsNot disclosed
  13. 13Blueprint MedicinesNot disclosed
  14. 14CytokineticsNot disclosed
  15. 15Intra-Cellular TherapiesNot disclosed
  16. 16Roivant SciencesNot disclosed
  17. 17Sarepta TherapeuticsNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.